Spirea
Pre-clinicalDevelops antibody-drug conjugates for cancer treatment using proprietary linker technology.
Founded
2019
Focus
AntibodiesBiologicsSmall Molecules
About
Develops antibody-drug conjugates for cancer treatment using proprietary linker technology.
Funding History
2Series AUndisclosedUndisclosedJun 15, 2022
SeedUndisclosedUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2019
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile